Schizophrenia Research
Volume 126, Issue 1 , Pages 265-269 , March 2011

Vocational rehabilitation improves cognition and negative symptoms in schizophrenia

Received 14 April 2010 ,Accepted 3 August 2010.

References 

  1. Adad MA, Castro R, Mattos P. Aspectos Neuropsicológicos da esquizofrenia. Rev. Bras. Psiquiatr. 2000;22:31–34
  2. American Psychiatric Association—APA . Diagnostic and Statical Manual Of Mental Disordes. 4th edition. 1994;Washington, DC.
  3. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am. J. Psychiatry. 1999;156:1349–1357
  4. Bell M, Bryson G. Work rehabilitation in schizophrenia: does cognitive impairment limit improvement?. Schizophr. Bull. 2001;27(2):260–279
  5. Bellack AS, Golg JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophr. Bull. 1999;25(2):257–274
  6. Bond GR, Resnick SG, Drake RE, Xie H, McHugo GJ, Bebout RR. Does competitive employment improve nonvocational outcomes for people with severe mental illness?. J. Consult. Clin. Psychol. 2001;69(3):489–501
  7. Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br. J. Psychiatry. 2009;195:475–482
  8. Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 1993;19:233–259
  9. Brekke SJ, Raine A, Ansel M, Lencz T, Bird L. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophr. Bull. 1997;23(1):19–28
  10. Bryson G, Bell M. Initial and final work performance in schizophrenia: cognitive and symptom predictors. J. Nerv. Ment. Dis. 2003;191:87–92
  11. Burton S. Symptom domains of schizophrenia: the role of atypical antipsychotic agents. J. Psychopharmacol. 2006;20(6 Suppl):6–19
  12. Chan S, Yu IW. Quality of life of clients with schizophrenia. J. Adv. Nurs. 2004;45(1):72–83
  13. Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, Gibson PJ, et al. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr. Res. 2004;70:331–342
  14. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L. A meta-analysis of cognitive déficits in adults with a diagnosis of schizophrenia. Neuropsychol. Rev. 2005;15:73–95
  15. Fiszdon JM, Choi J, Goulet J, Bell MD. Temporal relationship between change in cognition and change in functioning in schizophrenia. Schizophr. Res. 2008;105(1–3):105–113
  16. Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am. J. Psychiatry. 1999;156(12):1944–1950
  17. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental ilness. Am. J. Psychiatry. 2002;159:1395–1402
  18. Goldberg TE, Green MF. Neurocognitive Functioning in Patients with Schizophrenia: An Overview. In:  Davis KL,  Charney D,  Coyle JT,  Nemeroff C editor. Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins; 2002;p. 657–669
  19. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry. 1996;153:321–330
  20. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder?. Schizophr. Bull. 1999;25:309–319
  21. Heinrichs RW, Zakzains KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426–445
  22. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 1984;10:388–398
  23. Heinrichs RW, Ammari N, Miles A, Vaz SMD, Chopov B. Psychopatology and cognition in divergent functional outcomes in schizophrenia. Schizophr. Res. 2009;109:46–51
  24. Kay SR, Fizszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr. Bull. 1987;13:261–276
  25. Keefe RSE, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr. Bull. 1999;25:201–222
  26. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 2004;68(2–3):283–297
  27. Leeson VC, Barnes TER, Hutton SB, Ron MA, Joyce EM. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophr. Res. 2009;107(1):55–60
  28. Lysaker PH, Bell MD, Beam-Goulet J. Wisconsin car sorting test and work performance in schizophrenia. Psychiatry Res. 1995;56:45–51
  29. Lysaker PH, Bryson GJ, Davis LW, Bell MD. Relationship of impaired processing speed and flexibility of abstract thought to improvements in work performance over time in schizophrenia. Schizophr. Res. 2005;75:211–218
  30. Matza LS, Buchanan R, Purdon S, Brewster-Jordan J, Zhao Y, Revicki DA. Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Schizophr. Bull. 2006;32(4):666–678
  31. McGurk SR, Meltzer HY. The role of cognition in vocational functioning in schizophrenia. Schizophr. Res. 2000;27;45(3):175–184
  32. McGurk SR, Mueser KT. Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr. Res. 2004;70:147–173
  33. McGurk SR, Mueser KT. Cognitive and clinical predictors of work outcomes in clients with schizophrenia receiving supported employment services: 4-year follow-up. Adm. Policy Ment. Health Ment. Health Serv. Res. 2006;33:598–606
  34. McGurk SR, Mueser KT, Harvey PD, LaPuglia R, Marder J. Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatr. Serv. 2003;54:1129–1135
  35. McGurk SR, Mueser KT, DeRosa TJ, Wolfe R. Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr. Bull. 2009;35(2):319–335
  36. Meltzer HY, Mcgurk SR. The effect of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 1999;25:233–255
  37. O'Carrol R. Cognitive impairment in schizophrenia. Adv. Psychiatr. Treat. 2000;6:161–168
  38. Palmer BW, Heaton RK, Gladsjo JA, Evans JD, Patterson TL, Golshan S, et al. Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr. Res. 2002;55:205–215
  39. Peuskens J, Demily C, Thibaut F. Treatment of cognitive dysfunction in schizophrenia. Clin. Ther. 2005;27(Suppl A):S25–S37
  40. Poole JH, Ober BA, Shenaut GK, Vinogradov S. Independent frontal-system deficits in schizophrenia: cognitive, clinical, and adaptative implications. Psychiatry Res. 1999;85:161–176
  41. Riedel M, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, et al. Effect of aripiprazole on cognition in the tratment of patients with schizophrenia. Pharmacopsychiatry. 2010;43(2):50–57
  42. Rosenheck R, Leslie D, Keefe R, McEvoy J, Swartz M, Perkins D, et al. CATIE Study Investigators Group. Barriers to employment for people with schizophrenia. Am. J. Psychiatry. 2006;163:411–417
  43. Spreen O, Strauss E. A Compendium of Neuropsychological Tests. Oxford: Oxford University Press; 1998;
  44. Stip E. Memory impariament in schizophrenia: perspectives from psychopathology and pharmacotherapy. Can. J. Psychiatry. 1996;41:27S–34S
  45. Torrey WC, Mueser KT, McHugo GH, Drake RE. Self-esteem as an outcome measure in studies of vocational rehabilitation for adults with severe mental illness. Psychiatr. Serv. 2000;51(2):229–233
  46. van de Willige G, Wiersma D, Nienhuis FJ, Jenner JA. Changes in quality of life in chronic psychiatric patients: a comparison between EuroQol (EQ-5D) and WHOQoL. Qual. Life Res. 2005;14(2):441–451
  47. Wechsler D. (1997). WAIS III: Escala de Inteligência Wechsler para Adultos. Adaptação e padronização de uma amostra brasileira – Elizabeth do Nascimento. São Paulo: Casa do Psicólogo, 2004.
  48. Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 2005;8(3):457–472

PII: S0920-9964(10)01449-0

doi: 10.1016/j.schres.2010.08.003

Schizophrenia Research
Volume 126, Issue 1 , Pages 265-269 , March 2011

Article Tools